These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20001622)

  • 21. The hypercoagulable state in thalassemia intermedia.
    Taher AT; Musallam KM; Inati A
    Hemoglobin; 2009; 33 Suppl 1():S160-9. PubMed ID: 20001621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
    Voskaridou E; Douskou M; Terpos E; Papassotiriou I; Stamoulakatou A; Ourailidis A; Loutradi A; Loukopoulos D
    Br J Haematol; 2004 Sep; 126(5):736-42. PubMed ID: 15327528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thalassemia intermedia: revisited.
    Taher A; Isma'eel H; Cappellini MD
    Blood Cells Mol Dis; 2006; 37(1):12-20. PubMed ID: 16737833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble endothelial adhesion molecules and inflammation markers in patients with beta-thalassemia intermedia.
    Kanavaki I; Makrythanasis P; Lazaropoulou C; Tsironi M; Kattamis A; Rombos I; Papassotiriou I
    Blood Cells Mol Dis; 2009; 43(3):230-4. PubMed ID: 19654073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thalassemia intermedia today: should patients regularly receive transfusions?
    Aessopos A; Kati M; Meletis J
    Transfusion; 2007 May; 47(5):792-800. PubMed ID: 17465943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac involvement in thalassemia intermedia: a multicenter study.
    Aessopos A; Farmakis D; Karagiorga M; Voskaridou E; Loutradi A; Hatziliami A; Joussef J; Rombos J; Loukopoulos D
    Blood; 2001 Jun; 97(11):3411-6. PubMed ID: 11369631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac status in well-treated patients with thalassemia major.
    Aessopos A; Farmakis D; Hatziliami A; Fragodimitri C; Karabatsos F; Joussef J; Mitilineou E; Diamanti-Kandaraki E; Meletis J; Karagiorga M
    Eur J Haematol; 2004 Nov; 73(5):359-66. PubMed ID: 15458515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-thalassemia: the Lebanese experience.
    Inati A; Zeineh N; Isma'eel H; Koussa S; Gharzuddine W; Taher A
    Clin Lab Haematol; 2006 Aug; 28(4):217-27. PubMed ID: 16898958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complete heart block in thalassemia major: a case report.
    Küçükosmanoğlu O; Ozbarlas N; Saşmaz I
    Turk J Pediatr; 2002; 44(3):261-2. PubMed ID: 12405443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for a novel mechanism independent of myocardial iron in β-thalassemia cardiac pathogenesis.
    Stoyanova E; Cloutier G; Felfly H; Lemsaddek W; Ah-Son N; Trudel M
    PLoS One; 2012; 7(12):e52128. PubMed ID: 23284899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aortic valve replacement in a patient with thalassemia intermedia.
    Farmakis D; Polonifi A; Deftereos S; Tsironi M; Papaioannou I; Aessopos A
    Ann Thorac Surg; 2006 Feb; 81(2):737-9. PubMed ID: 16427892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydroxyurea in the management of thalassemia intermedia.
    Karimi M
    Hemoglobin; 2009; 33 Suppl 1():S177-82. PubMed ID: 20001623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies of left-ventricular function in anemia due to beta-thalassemia.
    Lewis BS; Lewis N; Dagan I; Rachmilewitz EA; Gotsman MS; Sapoznikov D
    Isr J Med Sci; 1982 Sep; 18(9):928-34. PubMed ID: 7141853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Beta-thalassemia: clinical manifestations].
    Perrimond H
    Bull Soc Pathol Exot; 2001 May; 94(2):92-4. PubMed ID: 11475035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Advances in pathogenesis and correlated clinical research of hypercoagulability in β thalassemia].
    Lv RY; Wen FQ; Yu J
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jul; 16(7):774-8. PubMed ID: 25008893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac abnormalities in the thalassaemia syndromes.
    Yee H; Mra R; Nyunt KM
    Southeast Asian J Trop Med Public Health; 1984 Sep; 15(3):414-21. PubMed ID: 6523177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of strain and tissue velocity imaging for early detection of regional myocardial dysfunction in patients with beta thalassemia.
    Hamdy AM
    Eur J Echocardiogr; 2007 Mar; 8(2):102-9. PubMed ID: 16564231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Standardized T2* map of a normal human heart to correct T2* segmental artefacts; myocardial iron overload and fibrosis in thalassemia intermedia versus thalassemia major patients and electrocardiogram changes in thalassemia major patients.
    Ramazzotti A; Pepe A; Positano V; Scattini B; Santarelli MF; Landini L; De Marchi D; Keilberg P; Derchi G; Formisano F; Pili M; Lai ME; Forni G; Filosa A; Prossomariti L; Capra M; Pitrolo L; Borgna-Pignatti C; Cianciulli P; Maggio A; Lombardi M
    Hemoglobin; 2008; 32(1-2):97-107. PubMed ID: 18274987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathophysiology of transfusional iron overload: contrasting patterns in thalassemia major and sickle cell disease.
    Porter JB
    Hemoglobin; 2009; 33 Suppl 1():S37-45. PubMed ID: 20001631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The interaction between heart failure and other heart diseases, renal failure, and anemia.
    Silverberg DS; Wexler D; Iaina A; Schwartz D
    Semin Nephrol; 2006 Jul; 26(4):296-306. PubMed ID: 16949468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.